These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 18954869)
1. How to avoid iatrogenic morbidity and mortality while increasing availability of oxytocin and misoprostol for PPH prevention? Lovold A; Stanton C; Armbruster D Int J Gynaecol Obstet; 2008 Dec; 103(3):276-82. PubMed ID: 18954869 [TBL] [Abstract][Full Text] [Related]
2. Oral misoprostol versus intramuscular oxytocin in the active management of the third stage of labour. Afolabi EO; Kuti O; Orji EO; Ogunniyi SO Singapore Med J; 2010 Mar; 51(3):207-11. PubMed ID: 20428741 [TBL] [Abstract][Full Text] [Related]
3. Misoprostol for the prevention and treatment of postpartum haemorrhage. Hofmeyr GJ; Gülmezoglu AM Best Pract Res Clin Obstet Gynaecol; 2008 Dec; 22(6):1025-41. PubMed ID: 18786863 [TBL] [Abstract][Full Text] [Related]
4. EFFECTIVENESS AND SAFETY OF 2-HOURLY 20 MCG ORAL MISOPROSTOL SOLUTION COMPARED TO STANDARD INTRAVENOUS OXYTOCIN IN LABOUR INDUCTION DUE TO PRE-LABOUR RUPTURE OF MEMBRANES AT TERM: A RANDOMISED CLINICAL TRIAL AT KENYATTA NATIONAL HOSPITAL. Mbaluka CM; Kamau K; Karanja JG; Mugo N East Afr Med J; 2014 Sep; 91(9):303-10. PubMed ID: 26866082 [TBL] [Abstract][Full Text] [Related]
5. Induction of labor with misoprostol in pregnancies with advanced maternal age. Zeteroglu S; Sahin GH; Sahin HA Eur J Obstet Gynecol Reprod Biol; 2006 Dec; 129(2):140-4. PubMed ID: 16406221 [TBL] [Abstract][Full Text] [Related]
6. Postpartum hemorrhage: evidence-based medical interventions for prevention and treatment. Rajan PV; Wing DA Clin Obstet Gynecol; 2010 Mar; 53(1):165-81. PubMed ID: 20142654 [TBL] [Abstract][Full Text] [Related]
7. Double-blind randomized controlled trial comparing misoprostol and oxytocin for management of the third stage of labor in a Nigerian hospital. Musa AO; Ijaiya MA; Saidu R; Aboyeji AP; Jimoh AA; Adesina KT; Abdul IF Int J Gynaecol Obstet; 2015 Jun; 129(3):227-30. PubMed ID: 25835642 [TBL] [Abstract][Full Text] [Related]
8. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women. Chaudhuri P; Biswas J; Mandal A Int J Gynaecol Obstet; 2012 Feb; 116(2):138-42. PubMed ID: 22100204 [TBL] [Abstract][Full Text] [Related]
9. Misoprostol as an adjunct to oxytocin can reduce postpartum-haemorrhage: a propensity score-matched retrospective chart review in Bamenda-Cameroon, 2015-2016. Morfaw F; Fundoh M; Pisoh C; Ayaba B; Mbuagbaw L; Anderson LN; Thabane L BMC Pregnancy Childbirth; 2019 Jul; 19(1):257. PubMed ID: 31331275 [TBL] [Abstract][Full Text] [Related]
10. Post-partum haemorrhage: beyond the confrontation between misoprostol and oxytocin. Buekens P; Althabe F Lancet; 2010 Jan; 375(9710):176-8. PubMed ID: 20109901 [No Abstract] [Full Text] [Related]
11. Oxytocin via Uniject (a prefilled single-use injection) versus oral misoprostol for prevention of postpartum haemorrhage at the community level: a cluster-randomised controlled trial. Diop A; Daff B; Sow M; Blum J; Diagne M; Sloan NL; Winikoff B Lancet Glob Health; 2016 Jan; 4(1):e37-44. PubMed ID: 26718808 [TBL] [Abstract][Full Text] [Related]
13. Comparison of induction of labor with vaginal misoprostol plus oxytocin versus oxytocin alone in term primigravidae. Balci O; Mahmoud AS; Acar A; Colakoglu MC J Matern Fetal Neonatal Med; 2011 Sep; 24(9):1084-7. PubMed ID: 21087166 [TBL] [Abstract][Full Text] [Related]
14. A prospective randomized study comparing misoprostol and oxytocin for premature rupture of membranes at term. Zeteroğlu S; Engin-Ustün Y; Ustün Y; Güvercinçi M; Sahin G; Kamaci M J Matern Fetal Neonatal Med; 2006 May; 19(5):283-7. PubMed ID: 16753768 [TBL] [Abstract][Full Text] [Related]
15. A randomised controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum haemorrhage. Al-Sawaf A; El-Mazny A; Shohayeb A J Obstet Gynaecol; 2013 Apr; 33(3):277-9. PubMed ID: 23550857 [TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy and safety of vaginal misoprostol versus dinoprostone vaginal insert in labor induction at term: a randomized trial. Ozkan S; Calişkan E; Doğer E; Yücesoy I; Ozeren S; Vural B Arch Gynecol Obstet; 2009 Jul; 280(1):19-24. PubMed ID: 19034471 [TBL] [Abstract][Full Text] [Related]
17. Randomized trial of preinduction cervical ripening: misoprostol vs oxytocin. Fonseca L; Wood HC; Lucas MJ; Ramin SM; Phatak D; Gilstrap LC; Yeomans ER Am J Obstet Gynecol; 2008 Sep; 199(3):305.e1-5. PubMed ID: 18771993 [TBL] [Abstract][Full Text] [Related]
18. Titrated oral misoprostol solution versus vaginal misoprostol for labor induction. Souza AS; Feitosa FE; Costa AA; Pereira AP; Carvalho AS; Paixão RM; Katz L; Amorim MM Int J Gynaecol Obstet; 2013 Dec; 123(3):207-12. PubMed ID: 24112746 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of postpartum blood loss after misoprostol-induced labour. Majoko F BJOG; 2009 Oct; 116(11):1533-4; author reply 1534-5. PubMed ID: 19769754 [No Abstract] [Full Text] [Related]
20. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction. Ramsey PS; Savage K; Lincoln T; Owen J Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]